Atomistry » Magnesium » PDB 3bdh-3bre » 3bjc
Atomistry »
  Magnesium »
    PDB 3bdh-3bre »
      3bjc »

Magnesium in PDB 3bjc: Crystal Structure of the PDE5A Catalytic Domain in Complex with A Novel Inhibitor

Enzymatic activity of Crystal Structure of the PDE5A Catalytic Domain in Complex with A Novel Inhibitor

All present enzymatic activity of Crystal Structure of the PDE5A Catalytic Domain in Complex with A Novel Inhibitor:
3.1.4.35;

Protein crystallography data

The structure of Crystal Structure of the PDE5A Catalytic Domain in Complex with A Novel Inhibitor, PDB code: 3bjc was solved by G.Chen, H.Wang, R.Howard, J.Cai, Y.Wan, H.Ke, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 30.00 / 2.00
Space group P 31 2 1
Cell size a, b, c (Å), α, β, γ (°) 73.755, 73.755, 132.509, 90.00, 90.00, 120.00
R / Rfree (%) 19.7 / 22.1

Other elements in 3bjc:

The structure of Crystal Structure of the PDE5A Catalytic Domain in Complex with A Novel Inhibitor also contains other interesting chemical elements:

Zinc (Zn) 1 atom

Magnesium Binding Sites:

The binding sites of Magnesium atom in the Crystal Structure of the PDE5A Catalytic Domain in Complex with A Novel Inhibitor (pdb code 3bjc). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Crystal Structure of the PDE5A Catalytic Domain in Complex with A Novel Inhibitor, PDB code: 3bjc:

Magnesium binding site 1 out of 1 in 3bjc

Go back to Magnesium Binding Sites List in 3bjc
Magnesium binding site 1 out of 1 in the Crystal Structure of the PDE5A Catalytic Domain in Complex with A Novel Inhibitor


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Crystal Structure of the PDE5A Catalytic Domain in Complex with A Novel Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Mg877

b:54.4
occ:1.00
OD1 A:ASP654 2.2 36.0 1.0
O A:HOH903 2.5 26.8 1.0
O A:HOH905 3.0 39.8 1.0
CG A:ASP654 3.1 30.8 1.0
OD2 A:ASP654 3.3 33.0 1.0
CD2 A:HIS657 3.5 25.7 1.0
NE2 A:HIS657 3.5 24.0 1.0
CD2 A:HIS613 3.7 26.5 1.0
NE2 A:HIS613 3.9 29.0 1.0
ZN A:ZN876 4.0 30.4 1.0
O A:HOH902 4.2 36.5 1.0
NE2 A:HIS685 4.4 28.3 1.0
CB A:ASP654 4.4 28.0 1.0
CG A:HIS613 4.6 28.3 1.0
CD2 A:HIS685 4.7 28.0 1.0
CG A:HIS657 4.8 24.5 1.0
O A:THR723 4.8 30.9 1.0
CE1 A:HIS657 4.8 23.8 1.0
CD2 A:HIS653 4.8 26.4 1.0
OE2 A:GLU682 4.9 37.8 1.0
CE1 A:HIS613 4.9 29.2 1.0
OG1 A:THR723 4.9 28.4 1.0
O A:HOH906 5.0 43.2 1.0
CA A:ASP654 5.0 26.6 1.0

Reference:

G.Chen, H.Wang, H.Robinson, J.Cai, Y.Wan, H.Ke. An Insight Into the Pharmacophores of Phosphodiesterase-5 Inhibitors From Synthetic and Crystal Structural Studies Biochem.Pharm. V. 75 1717 2008.
ISSN: ISSN 0006-2952
PubMed: 18346713
DOI: 10.1016/J.BCP.2008.01.019
Page generated: Wed Aug 14 09:10:29 2024

Last articles

Zn in 9J0N
Zn in 9J0O
Zn in 9J0P
Zn in 9FJX
Zn in 9EKB
Zn in 9C0F
Zn in 9CAH
Zn in 9CH0
Zn in 9CH3
Zn in 9CH1
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy